AT
Healthcare & Life Sciences
Agnos Therapeutics
United Stateswww.agnostx.com/
Agnos Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Pre-Seed, 1 tracked investor.
Activepre-seed
pre-seed
Stage
1
Investors
About Agnos Therapeutics
Agnos Therapeutics is a company headquartered in the United States. Its most recent tracked round is Pre-Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Agnos Therapeutics develops a mutation-agnostic retinal cell therapy using induced pluripotent stem cell technology to restore vision in patients with inherited blindness by rescuing surviving photoreceptors regardless of the underlying genetic mutation.
Explore Agnos Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.